Home > News > Nanoscale Diagnostic Sets Sights on Alzheimer's
January 31st, 2005
Nanoscale Diagnostic Sets Sights on Alzheimer's
Abstract:
Using their novel bio-bar-code amplification (BCA) technology, researchers analyzing fluid from around the brain and spinal cord have detected a protein linked in recent studies to Alzheimer's disease.
If proven successful in further clinical studies, the procedure could become the first tool for early diagnosis of Alzheimer's, and the first test to conclusively identify the disease in living patients.
Chad Mirkin and William Klein of the National Science Foundation (NSF) Nanoscale Science and Engineering Center (NSEC) for Nanopatterning and Detection Technologies at Northwestern University, and their colleagues, announce their findings the week of Jan. 31 in the online edition of the Proceedings of the National Academy of Sciences
Source:
NSF
Bookmark:
Possible Futures
Space Solar Power: Key to a Livable Planet Earth June 10th, 2013
Global Nanotechnology Drug Delivery Market 2012-2016 June 10th, 2013
Nanorobot tetanus treatment animation June 9th, 2013
New horizons to drive the future of Medicine: European Technology Platform on Nanomedicine intends to lead the domain June 8th, 2013
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013